These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27357023)
1. Efficient [(18)F]AlF Radiolabeling of ZHER3:8698 Affibody Molecule for Imaging of HER3 Positive Tumors. Da Pieve C; Allott L; Martins CD; Vardon A; Ciobota DM; Kramer-Marek G; Smith G Bioconjug Chem; 2016 Aug; 27(8):1839-49. PubMed ID: 27357023 [TBL] [Abstract][Full Text] [Related]
2. Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules. Rinne SS; Dahlsson Leitao C; Saleh-Nihad Z; Mitran B; Tolmachev V; Ståhl S; Löfblom J; Orlova A Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183096 [TBL] [Abstract][Full Text] [Related]
3. Increase in negative charge of Rinne SS; Dahlsson Leitao C; Gentry J; Mitran B; Abouzayed A; Tolmachev V; Ståhl S; Löfblom J; Orlova A Sci Rep; 2019 Nov; 9(1):17710. PubMed ID: 31776413 [TBL] [Abstract][Full Text] [Related]
4. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts. Persson M; Liu H; Madsen J; Cheng Z; Kjaer A Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763 [TBL] [Abstract][Full Text] [Related]
5. Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment. Glaser M; Iveson P; Hoppmann S; Indrevoll B; Wilson A; Arukwe J; Danikas A; Bhalla R; Hiscock D J Nucl Med; 2013 Nov; 54(11):1981-8. PubMed ID: 24115530 [TBL] [Abstract][Full Text] [Related]
6. An Efficient Method for Labeling Single Domain Antibody Fragments with Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599 [TBL] [Abstract][Full Text] [Related]
7. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging. Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression. Rosestedt M; Andersson KG; Mitran B; Rinne SS; Tolmachev V; Löfblom J; Orlova A; Ståhl S Int J Oncol; 2017 Dec; 51(6):1765-1774. PubMed ID: 29039474 [TBL] [Abstract][Full Text] [Related]
9. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of [ Huang J; Bai L; Shi D; Jiang W; Chen P; Dong Y; Zhang X; Peng J; Hou J; Lu Y; Huang X; Tang G; Huang S Mol Pharm; 2024 May; 21(5):2425-2434. PubMed ID: 38554143 [TBL] [Abstract][Full Text] [Related]
11. Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [ Da Pieve C; Makarem A; Turnock S; Maczynska J; Smith G; Kramer-Marek G Molecules; 2020 Mar; 25(7):. PubMed ID: 32235296 [TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [ Fersing C; Bouhlel A; Cantelli C; Garrigue P; Lisowski V; Guillet B Molecules; 2019 Aug; 24(16):. PubMed ID: 31394799 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging. Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607 [TBL] [Abstract][Full Text] [Related]
14. Comparison of renal clearance of [ Liu J; Guo X; Wen L; Wang L; Liu F; Song G; Zhu H; Zhou N; Yang Z Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2775-2786. PubMed ID: 37093312 [TBL] [Abstract][Full Text] [Related]
15. HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging. Martins CD; Da Pieve C; Burley TA; Smith R; Ciobota DM; Allott L; Harrington KJ; Oyen WJG; Smith G; Kramer-Marek G Clin Cancer Res; 2018 Apr; 24(8):1853-1865. PubMed ID: 29437790 [No Abstract] [Full Text] [Related]
16. Imaging Early-Stage Metastases Using an Mason CA; Carter LM; Mandleywala K; de Souza Franca PD; Meyer JP; Mamun T; Backer JM; Backer MV; Reiner T; Lewis JS Mol Imaging Biol; 2021 Jun; 23(3):340-349. PubMed ID: 33156495 [TBL] [Abstract][Full Text] [Related]
17. Comparison of three dimeric 18F-AlF-NOTA-RGD tracers. Guo J; Lang L; Hu S; Guo N; Zhu L; Sun Z; Ma Y; Kiesewetter DO; Niu G; Xie Q; Chen X Mol Imaging Biol; 2014 Apr; 16(2):274-83. PubMed ID: 23982795 [TBL] [Abstract][Full Text] [Related]
18. Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules. Rinne SS; Xu T; Dahlsson Leitao C; Ståhl S; Löfblom J; Orlova A; Tolmachev V; Vorobyeva A Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075258 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide. Hausner SH; Bauer N; Sutcliffe JL Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053 [TBL] [Abstract][Full Text] [Related]
20. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1. Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]